“This is another case study that demonstrates how the seed grant program for neurological research is designed to work,” stated Terre Constantine, Ph.D., Executive Director of BRF. “With a modest investment by BRF and the strong results that were produced, funding of important research can be expanded rapidly and with a high confidence level.” BRF provides seed grants to novel, early stage scientific research that would otherwise go unfunded, which puts the science at risk of not moving forward. Dr. Allada’s work adds to the emerging area of cognitive decline which has deep need for more science.
Dr. Allada’s new grant was awarded by The Defense Advanced Research Project Agency and will be awarded over four years.
Established to help innovative neuroscience researchers gather the data required to validate their hypotheses, the BRF Seed Grants are a critical first step in understanding neurological disorders. Since 1981, BRF has awarded more than $9.6 million to fund early stage research focused on novel ideas. By enabling scientists to generate the preliminary data required for major grants, the Foundation estimates that its investments have led to a factor of ten times more funding for grantees and research.
About the Brain Research Foundation
The Brain Research Foundation supports cutting-edge neuroscience research that will lead to novel treatments and prevention of all neurological diseases in children and adults. We deliver this commitment through research grants, which provide initial funding for innovative projects, as well as educational programs for researchers and the general public.
For more information, please visit our website http://www.thebrf.org. You can friend us on Facebook at www.facebook.com/